FDA Tells Doctors in 8 States to Stop Using COVID-19 Treatment
Coronavirus,FDA,Monoclonal Antibodies
U.S. drug regulators have directed health care workers in eight states to stop using a COVID-19 treatment because it may not be effective against an Omicron coronavirus subvariant that’s rising in prevalence.
The Food and Drug Administration (FDA) said sotrovimab, a monoclonal antibody used to treat COVID-19, can no longer be used in Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Rhode Island, and Vermont.
Providers in Puerto Rico and the Virgin Islands also have been told to stop using stotrovimab.
Regulators believe that the treatment, which was given emergency use authorization in May 2021, “is unlikely to be effective against the BA.2 subvariant,” the FDA said in a statement.
Related Coverage
AllSides Picks
Red Blue Translator
Anti-vaxxer
Headline Roundup
SCOTUS Denies Trump's Appeal to Cut DEI Funding to University of California
November 16th, 2026
Headline Roundup
Study Suggests Hormone Therapy Regrets Are 'Rare' Among Trans Youth, Media Split on Its Credibility
November 16th, 2026
Recommended Reading
When Democrats Have To Decide
Dan Schnur
November 16th, 2026